SM
EW icon

Sabby Management’s Edwards Lifesciences EW Stock Holding History

Sabby Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-7,431
Closed -$21.9M – 306
2016
Q1 		$21.9M Buy
+7,431
New +$205K 1.09% 17
2014
Q1 		– Sell
-10,188
Closed -$11.2M – 247
2013
Q4 		$11.2M Hold
10,188
– – 0.71% 31
2013
Q3 		$11.8M Hold
10,188
– – 0.77% 34
2013
Q2 		$11.4M Buy
+10,188
New +$121K 0.76% 36

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Sabby Management's EW Position: Q1 2016 in Review

Sabby Management sold out of Edwards Lifesciences (EW) in Q1 2016, closing a stake of 18,321 shares — an estimated $506K sold.

Sabby Management first reported a position in EW in Q2 2015 and held it in 3 quarters. The position peaked at $11M in Q3 2015. 658 funds tracked by Wall St. Rank hold EW as of Q1 2016.

  • Sabby Management reported no remaining Edwards Lifesciences position as of Q1 2016 after selling out during the quarter.
  • Sabby Management sold 18,321 Edwards Lifesciences shares in Q1 2016, an estimated $506K.
  • Sabby Management first reported a position in Edwards Lifesciences in Q2 2015 and held it in 3 quarters.
  • Sabby Management's Edwards Lifesciences position peaked at $11M in Q3 2015.
  • 658 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2016.

Based on Sabby Management's 13F filing for Q1 2016, filed 13 May 2016.